Economic Considerations for Implementing Tobacco Cessation Programs in Cancer Care Settings

Area of Science:

• Health Economics
• Oncology
• Public Health

Background:

• Growing evidence supports the economic advantages of tobacco cessation interventions within cancer care settings.
• Hospital-based cessation programs face implementation challenges due to economic barriers and misaligned payment models in fee-for-service systems.
• The financial value of these programs is often underestimated, impacting their integration into standard cancer care.

Purpose of the Study:

• To evaluate the economic benefits, specifically healthcare cost savings, associated with a tobacco cessation program in a cancer care setting.
• To analyze the factors influencing the implementation and sustainability of tobacco cessation programs within hospitals.
• To underscore the importance of integrating economic evaluation and implementation research for program decision-making.

Main Methods:

• Analysis of healthcare costs for patients participating in a tobacco cessation program at MD Anderson Cancer Center.
• Assessment of median cost savings per patient over a defined period (3 months).
• Review of economic barriers, stakeholder incentives, and payment structures affecting program implementation.

Main Results:

• Median healthcare cost savings of $1,095 per patient were observed over a 3-month period.
• The study highlights a significant return on investment for tobacco cessation initiatives in cancer care.
• Implementation decisions are frequently hindered by economic disincentives and system-level payment issues.

Conclusions:

• Tobacco cessation programs offer substantial economic benefits, demonstrating significant cost savings in cancer care.
• A comprehensive approach combining economic evaluation with implementation research is crucial for enhancing program sustainability.
• Addressing economic barriers and aligning payment models are essential for effective integration of cessation programs in US healthcare settings.